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One Sentence Summary: Metal ion coordination underlies both strengths and 
weaknesses of HIV strand transfer inhibitors. 
 
Abstract:  
Although second-generation HIV integrase strand-transfer inhibitors (INSTIs) 
are prescribed throughout the world, the mechanistic basis for the superiority of 
these drugs is poorly understood. We used single-particle cryo–electron 
microscopy to visualize the mode of action of the advanced INSTIs dolutegravir 
and bictegravir at near-atomic resolution. Glutamine-148→histidine (Q148H) and 
glycine-140→serine (G140S) amino acid substitutions in integrase that result in 
clinical INSTI failure perturb optimal magnesium ion coordination in the enzyme 
active site. The expanded chemical scaffolds of second-generation compounds 
mediate interactions with the protein backbone that are critical for antagonizing 
viruses containing the Q148H and G140S mutations. Our results reveal that 
binding to magnesium ions underpins a fundamental weakness of the INSTI 
pharmacophore that is exploited by the virus to engender resistance and provide 
a structural framework for the development of this class of anti-HIV/AIDS 
therapeutics. 
 
Main text: Despite immediate clinical impact, the first in-class INSTI raltegravir 
(RAL) suffered setbacks from the emergence of viral resistance (1). Although second-
generation INSTIs dolutegravir (DTG) and bictegravir (BIC) display improved activity 
against RAL-resistant strains (2, 3), the advanced compounds are not immune to 
resistance (3-7). In particular, Q148H/G140S changes in HIV-1 IN are associated with 
complete or partial loss of efficacy across the entire drug class. The mode of INSTI 
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binding to the IN active site was first visualized in the context of the prototype foamy 
virus (PFV) intasome (8). However, the limited ~15% amino acid sequence identity 
between PFV and HIV-1 INs greatly restricts the utility of PFV for studies of INSTI 
resistance and precludes its use as a template for structure-based lead optimization. 
Conversely, unfavorable biochemical properties of the HIV-1 intasome have impeded 
structural refinements to atomic resolution (9).  
In order to establish a robust experimental system suitable for informing INSTI 
development, we evaluated IN proteins from primate lentiviruses that are highly related 
to circulating strains of HIV-1. The simian immunodeficiency virus from red-capped 
mangabeys (SIVrcm) is a direct ancestor of chimpanzee SIV (10, 11). Because the HIV-
1 pol gene is originally derived from SIVrcm, the viruses share as much as 75% IN 
amino acid sequence identity (fig. S1). SIVrcm IN displayed robust strand transfer 
activity in vitro, which was stimulated by the lentiviral IN host factor LEDGF/p75 (12, 
13). Reaction conditions were conducive for the formation of stable nucleoprotein 
complexes, which were competent for strand transfer activity and sensitive to INSTI 
inhibition (figs S2, S3A). Examination of the material by negative stain electron 
microscopy (EM) revealed a heterogenous population with the prominent presence of 
long linear polymers (hereafter referred to as stacks, Fig. 1A). Reference-free 
classification revealed 2D averages that were strikingly similar to those observed in 
maedi-visna virus (MVV) intasome preparations (Fig. 1A, fig. S4) (14). However, 
while the latter behaved as a near-monodispersed population with a predominance of 
hexadecamers (tetramer-of-tetramers) of IN, the flanking IN tetramers of SIVrcm 
intasomes were notably disordered, often nucleating stack formation. Although HIV-1 
IN assembly was much less efficient, it yielded particles visually indistinguishable from 
SIVrcm intasomes (figs S3B, S5-6). These observations are consistent with 
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polydispersity previously reported in HIV-1 intasomes assembled with a hyperactive 
IN mutant (9). 2D class averages apparently corresponding to the dodecameric 
assembly from that study were readily identified in our wild type HIV-1 and SIVrcm 
intasome images (Fig. 1A, fig. S5). 
We recorded micrograph movies of unstained SIVrcm intasome stacks in 
vitreous ice using a direct electron detector and refined the cryo-EM structure of an 
averaged intasome repeat unit. To prevent DNA binding to the target binding groove, 
which would occlude INSTI occupancy (15), the intasomes were prepared using 
A119D IN that precludes target DNA capture without affecting IN active site function 
(16-18). The overall resolution of the reconstruction throughout the conserved intasome 
core (CIC) was 3.3 Å, while the local resolution of the active site region approached 
2.8 Å (figs S7-8, table S1). In agreement with the resolution metrics, the cryo-EM 
density map was sufficiently detailed to build and refine an atomic model (fig. S9). The 
resulting model encompassed two IN tetramers with associated viral DNA ends, as well 
as two pairs of C- and N-terminal domains (CTDs and NTDs) donated by flanking stack 
units (Fig. 1B, C). Exchange of NTDs and CTDs between neighboring intasomes forms 
the structural basis for stack formation (Fig. 1B, fig. S10). 
Using available nucleotide sequence data (10), we engineered recombinant 
SIVrcm and evaluated its sensitivity to INSTIs (fig. S11A). First- (RAL) and second- 
(DTG, BIC) generation INSTIs inhibited HIV-1 and SIVrcm at similar half-maximal 
effective concentrations (EC50) (Fig. 2A). Q148H/G140S changes in IN rendered 
HIV-1 and SIVrcm significantly resistant to RAL, by a factor of >2000, whereas EC50 
values of the second-generation INSTIs BIC and DTG increased similarly ~5- to-8-fold 
against HIV-1 and 40 to 73-fold against SIVrcm (fig. S11B). Importantly, the majority 
of residues that when altered confer INSTI resistance are conserved between HIV-1 
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and SIVrcm (fig. S1). An exception is Thr138: in HIV-1, E138T potentiates resistance 
of Q148H-containing viruses (19, 20). Concordantly, reverting Thr138 to Glu 
decreased DTG and BIC resistance of Q148H/G140S SIVrcm to the levels observed 
with HIV-1 Q148H/G140S. Moreover, T97A/L74M, which increase resistance of 
Q148H/G140S HIV-1 to second-generation INSTIs (7), exerted the same effect on 
SIVrcm (fig. S11B). 
Encouraged by these results, we acquired cryo-EM data on SIVrcm intasomes 
vitrified in the presence of INSTIs and Mg2+ ions. DTG- and BIC-bound structures 
were reconstructed to resolutions of 3.0 and 2.6 Å across the CIC, with local resolutions 
within active site regions of 2.8 and 2.4 Å, respectively (figs S7-8, table S1). The 
inhibitors were defined remarkably well in density maps, allowing their refinements 
with bound Mg2+ ions and associated water molecules (fig. S12-13, movie S1). The 
invariant IN active site carboxylates Asp64, Asp116, and Glu152 coordinate a pair of 
Mg2+ ions, which in turn interact with the metal chelating cores of the INSTIs (Fig. 2B, 
C). As previously observed in PFV intasome crystals (8), the drugs displace the 3' viral 
DNA nucleotide, which stacks against the central body of the INSTI (fig. S14). In 
agreement with low-level amino acid sequence identity, there are considerable 
differences in the environment of the small molecules in the SIVrcm and PFV structures 
(fig. S15). 
The map of the BIC complex revealed an interaction between the side chain 
amide of Gln148 and the carboxylates of metal-chelating residues Glu152 and Asp116 
via a water molecule (W5, Fig. 2B). Molecular dynamics simulations confirmed 
stability of this hydrogen bonding network (fig. S16A). DTG and BIC intimately 
contact the backbone atoms of Asn117 and Gly118 from the IN 4-2 connector, 
making respectively 8 and 12 contacts with interatomic distances ≤5 Å. Moreover, BIC 
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makes three contacts with interatomic distances of 3.9-4.0 Å within this region of the 
active site. We obtained a truncated INSTI derivative lacking the heterocycle involved 
in these interactions to test their importance to drug potency (analogue 1, Fig. 3A). This 
modification was not expected to impact the metal chelating properties of the 
compound or its ability to stack with DNA bases, and indeed analogue 1 and DTG 
similarly inhibited HIV-1 infection. However, in contrast to DTG, analogue 1 was ~80-
fold less effective against HIV-1 Q148H/G140S (Fig. 3B). In agreement with published 
work (21), the amino acid substitutions increased the dissociative rate of DTG from 
HIV-1 intasomes, while their impact on the truncated derivative was much greater (Fig. 
3A). Collectively, these data implicate contacts with the 4-2 connector as a crucial 
feature of the second-generation INSTIs. 
To visualize the impact of the Q148H/G140S substitutions on drug binding, we 
imaged mutant SIVrcm intasomes in complex with BIC to a local resolution of 2.8 Å 
(figs S7-8, S17A, table S1). Ser140 and His148 side chains directly interact, and the 
latter positioned within 3.3 Å of the metal-chelating Glu152 carboxylate (Fig. 2D, fig. 
S17B). In the refined model, steric clashes between the side chains are avoided by a 
0.5-Å shift at the His148 C atom. Importantly, local crowding due to insertion of the 
mutant His148 side chain expelled water molecule W5 (fig. S16B), thus disturbing the 
secondary coordination shell of the Mg2+ ions. We also note that the amino acid changes 
caused a ~0.5-Å shift in the position of the bound drug; while arguably minor given the 
resolution of the cryo-EM map, the observed displacement agrees precisely with 
predictions by computational chemistry, illustrating the effect of the substitutions on 
drug binding. The N2 atom of His148 intimately contacts the carboxylate of Glu152 
(3.3 Å, fig. S17), which is involved in bidentate coordination with one of the Mg2+ 
atoms. Importantly, the acidity of His148 N2 is increased due to hydrogen bonding of 
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N1 with Ser140 (Fig. 2D). The Ser140-His148-Glu152 coupling is strikingly 
reminiscent of the non-catalytic Ser-His-Glu triad proposed as a stability determinant 
in -amylases, representing a reversal of the charge relay system in hydrolase active 
sites (22, 23). However, hydrogen bonding would require reorientation of IN Glu152 
and His148 side chains, which would be incompatible with Mg2+ ion coordination and 
drug binding, suggesting an empirical interpretation of the INSTI resistance 
mechanism.  
Our simulations show that analogue 1 is considerably more dynamic in the 
active site compared to the full-sized molecule, the mobility of which is restricted 
through interactions with the 4-2 connector (fig. S18). The additional degree of 
freedom is expected to allow more extensive re-orientation of the truncated inhibitor, 
which may permit His148 to withdraw more electron density from the Mg2+-ligand 
cluster. Our natural bond orbital analysis illustrates the changes of atomic charge 
distribution within the cluster in response to polarization by protonated His148 N2 and 
subtle conformational adaptations (fig. S19). It is easy to extend these observations to 
the other substitutions at position 148, Lys and Arg, both of which introduce 
electropositive functionalities to yield high-level INSTI resistance (4).  
Further work will be required to unravel long-range interactions involved in 
boosting INSTI resistance by secondary changes such as E138T and L74M/T97A (19, 
20). As a start, we analyzed respective side chains in our SIVrcm Q148H/G140S 
intasome structure. Thr138 is ideally positioned to hydrogen bond with N1 of 
conserved residue His114, prompting it to donate its N2 proton to Ser140 (Fig. 2E, 
fig. S20). This extended network, which may form a proton wire, is expected to 
reinforce Ser140 as a hydrogen bond donor for its interaction with His148 N1, 
explaining why the E138T substitution can enhance the resistance of Q148H/G140S 
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HIV-1 (19, 20). SIVrcm IN residues Ile74 (the position occupied by Leu or Ile in HIV-1 
strains) and Thr97 are in close proximity to the side chain of conserved Phe121, which 
is involved in van der Waals interactions with the metal-chelating carboxylate of 
Asp116 (Fig. 2F, fig. 21A). Readjustment of the Phe121 side chain in response to 
changes in its local packing environment serves as a likely conduit to perturb the 
structural integrity of the metal-chelating cluster (fig. S21B). 
The interactions with Mg2+ ions, which are nearly covalent in nature, are partly 
responsible for the extraordinary tight binding of INSTIs. Our results reveal that the 
chink in the armor of this drug class, exploited by the virus, is the extreme sensitivity 
of metal ions for the precise geometry and electronic properties of the ligand cluster 
(24, 25). Each DNA-bound IN active site within the intasome catalyzes just one strand 
transfer event, allowing the virus to balance INSTI resistance by detuning its active site 
while retaining sufficient replication capacity. However, extending the small molecules 
towards the IN backbone helps to stabilize optimal binding geometry and improve the 
resilience of the drug in the face of INSTI resistance mutations. We note that although 
DTG and BIC maximally extend to the 4-2 connector, they leave substantial free 
space in the IN active site, which is occupied by solute molecules in our structures 
(movie S1). Extension of the INSTI scaffolds to fill this space should be explored for 
the development of improved compounds. 
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FIGURE LEGENDS 
Fig. 1: Reconstruction of the SIVrcm intasome core. (A) Raw image (left) and 2D 
class averages (right) of negatively stained SIVrcm intasome particles; apparent 
numbers of IN subunits are indicated for non-stacked classes. Particle distributions are 
given in fig. S4. The envelope of the hexadecameric maedi-visna virus intasome (red 
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circle; central and flanking IN tetramers in blue/green and yellow, respectively) is 
shown for comparison; scale bars are 0.2 nm. (B) Atomistic reconstruction of the 
SIVrcm intasome stack shown as space fill (left) and cartoons (right); separate repeat 
units are shown in alternating red and green colors. (C) Detailed view of a single 
intasomal repeat representing a pair of viral DNA ends (vDNA, grey cartoons) 
synapsed between a pair of IN tetramers (composed of yellow, orange, pink, and either 
green or cyan IN protomers; the active sites of the green and cyan molecules (red dots) 
catalyze DNA recombination). The repeat unit is completed by pairs of C-terminal 
(orange) and N-terminal (dark magenta) domains donated by IN chains belonging to 
neighboring repeats. These CTDs are critical to form the conserved intasome core 
(CIC), which is shown in space fill mode in the middle panel. CCD, catalytic core 
domain. 
 
Fig. 2:  Binding modes of second generation INSTIs in the IN active site. (A) 
Chemical structures of select first- (RAL) and second-generation (DTG, BIC) INSTIs 
(left; halo-benzyl groups in blue and metal-chelating oxygen atoms in red) and viral 
sensitivities (right). Results are averages and standard deviations of minimally n = 2 
experiments, with each experiment conducted in triplicate; EC50 values are noted. (B) 
Active site of the SIVrcm intasome in complex with BIC; protein, DNA, and drug are 
shown as sticks. Blue spheres are Mg2+ ions, water molecules are shown as small red 
spheres. (C) Superposition of BIC (magenta) and DTG (yellow) bound structures with 
protein and DNA shown in space-fill mode. Yellow lines accentuate proximity to IN 
4-2 connector. (D) Q148H/G140S active site bound to BIC. + indicates increased 
electropositivity of the His148 N2 proton. (E) The extended hydrogen bond network 
that couples Thr138 to His148 in the Q148H/G140S SIVrcm intasome. Black arrows 
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indicate hydrogen bond donation; the corresponding interatomic distances are given in 
Ångstroms. Cryo-EM map of the same region is shown in fig. S20. (F) Long-range 
interactions of Ile74 and Thr97 with the metal chelating cluster via Phe121. Key amino 
acid residues are shown as sticks and semi-transparent van der Waals surfaces. Contacts 
between side chain atoms are indicated by double-headed dotted arrows with distances 
given in Ångstroms. Cryo-EM map showing definition of the side chain rotamers and 
the effects of I74M/T97A substitutions on the Phe121 side chain are shown in fig. S21.  
 
Fig. 3: Effects of Q148H/G140S substitutions on DTG and analogue 1 activities. 
(A) Structure of analogue 1 (top; colors as in Fig. 2A) and a time course of 3H-DTG 
and analogue 1 dissociation from wild type and Q148H/G140S HIV-1 intasomes 
(bottom). Results from three independent experiments are plotted; each data point is an 
average of two measurements done in parallel; trendlines are for illustration purpose. 
Apparent INSTI dissociative half-times from the mutant intasome are indicated. (B) 
Activities of DTG and analogue 1 against wild type (top) and Q148H/G140S (bottom) 
HIV-1. Results are averages and standard deviations of two independent experiments, 
with each experiment conducted in triplicate. 
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Materials and Methods 
Protein expression and purification 
Codon-optimized DNA fragments encoding various SIV INs were cloned between XmaI and 
BamHI sites of pCPH6P (12) to produce proteins with cleavable N-terminal hexahistidine 
tags. The amino acid sequence of SIVrcm IN was derived from NCBI entry HM803689 (10), 
and the A119D mutation was introduced using QuikChange procedure (Stratagene). 
Recombinant lentiviral INs were produced essentially as previously described (12, 13). 
Briefly, protein expression was induced in Endonuclease A-negative Escherichia coli PC2 
cells (12) grown in LB medium with 0.01% isopropyl β-D-1-thiogalactopyranoside (IPTG) 
at 25 oC. Cells were lysed by sonication in buffer A containing 20 mM Tris-HCl pH 7.5, 1 M 
NaCl, 0.5% 3-[(3-cholamidopropyl) dimethylammonio]-1-propane sulfonate (CHAPS) 
supplemented with 1 mM phenylmethylsulfonyl fluoride and cOmplete EDTA-free protease 
inhibitor cocktail (Roche). Supernatant pre-cleared by centrifugation was incubated with 
NiNTA agarose (Qiagen) at 4°C in the presence of 20 mM imidazole.  The resin was washed 
with buffer A containing 20 mM imidazole and recombinant protein was eluted in buffer A 
containing 200 mM imidazole.  Peak fractions were supplemented with 10 mM dithiothreitol 
(DTT) and incubated with human rhinovirus 3C protease (1:50 w/w ratio) at 4°C overnight 
to remove the hexahistidine tag. The protein was diluted to 150 mM NaCl in 25 mM Tris-
HCl pH 7.5, 0.5% CHAPS and loaded onto a 5-ml HiTrap Heparin column (GE Healthcare). 
The protein was eluted with a linear 0.15-1 M NaCl gradient; peak fractions were 
supplemented with 2 mM DTT and NaCl to a final concentration of 1 M. Purified SIVrcm 
IN, concentrated using a 10-kDa cut-off Vivaspin device (Generon) to 11-15 mg/ml, was 
supplemented with 10% glycerol, flash frozen in liquid nitrogen and stored at -80°C. Full-
length recombinant LEDGF/p75 and HIV-1 IN (wild type (WT) or Q148H/G140S) were 
initially produced as hexahistidine-tagged forms, which were cleaved and removed during 
purification according to published procedures (13, 26).  
 
Strand transfer assays 
Viral DNA (vDNA) modelled on the U5 end of SIVrcm was prepared by annealing synthetic 
oligonucleotides 5'- GGCTAAGAAAAATCTCTACCA (pre-processed vDNA plus-strand) 
and 5'- AACTGGTAGAGATTTTTCTTAGCC (non-transferred minus-strand). For activity 
assays, 0.5 µM vDNA and 300 ng pGEM target DNA were incubated with IN (0 - 8 µM) and 
LEDGF/p75 (0 - 16 µM) in the presence of 40 mM KCl, 5 mM MgSO4, 4 µM ZnCl2, 5 mM 
DTT, 20 mM BisTris propane (BTP), pH 6.0 in a final volume of 40 µl. Reactions were 
allowed to proceed for 45 min at 37°C and stopped by addition of 0.25% sodium dodecyl 
sulfate (SDS) and 12.5 mM EDTA. Following ethanol precipitation, reaction products were 
separated by electrophoresis through 1.5% agarose gels in tris-acetate and visualized with 
ethidium bromide (fig. S2). 
 
INSTIs 
DTG and BIC were purchased from MedChem Express, and analog 1 was synthetized by 
Giotto Biotech. For use in scintillation proximity assays (SPAs) (Fig. 3A), DTG and analog 1 
were labeled via tritium gas exchange on a hydrogen transfer catalyst to respective specific 
activities of 8.4 and 12 Ci/mmol and purified to radiochemical purity of >98% (Moravek). 
 
Preparation of the intasomes 
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SIVrcm (WT or A119D) were assembled by incubating 8 µM IN and 8 µM LEDGF with 4 
µM vDNA or 0.75 µM strand transfer product DNA (for assembly of the post-catalytic strand 
transfer complex) in 55-61 mM NaCl, 3 mM CaCl2, 1 mM DTT, 10 µM ZnCl2 and 25 mM 
BTP - HCl, pH 6.0 at 37°C for 10 min. The mixtures, cooled on ice for 2 min, were 
supplemented with NaCl to a final concentration of 350 mM, and incubated for further 10 
min on ice to dissociate unproductive protein-DNA aggregates. The assembly products, 
concentrated on a 10-kDa cut-off Vivaspin device to a final volume of 50 µl, were separated 
by size exclusion chromatography through a 300 x 7.8 mm TSKgel UltraSW aggregate 
column (Tosoh Bioscience, part number 0022856) in 350 mM NaCl, 25 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) - NaOH, pH 7.0. Pre-processed 
vDNA was prepared by annealing oligonucleotides 5'-biotin-tetraethyleneglycol (TEG) - 
GTTCTAGAAGGCTAAGAAAAATCTCTACCA and 5'- AACTGGTAGAGATTTTT 
CTTAGCCTTCTAGAAC. Crossover DNA mimicking the product of strand transfer was 
made by annealing oligonucleotides 5'- biotin - TEG - GGCTAAGAAAAATCTCTAC 
CAggccccacgctgcctcgggtagggg, 5'- biotin - TEG - GGCTAAGAAAAATCTCTACCAgg 
gcccacgctgcctcgggtagggg, 5'-CCCCTACCCGAGGCAGCGTG, and 5'-AACTGGTAGA 
GATTTTTCTTAGCC (upper case characters represent SIVrcm U5-derived sequence, lower 
case characters represent the target DNA portion of the crossover construct). Addition of the 
5' biotin modification to non-reactive vDNA ends appeared to enhance intasome formation 
in some cases. Synthetic HPLC-grade oligonucleotides for intasome assembly were obtained 
from Sigma-Aldrich. The INSTI complexes for cryo-EM were formed by incubation of the 
purified SIVrcm A119D intasome in the presence of 5 mM MgSO4 and 50 µM DTG or BIC 
at room temperature for 15-20 min and then on ice for a further 30-60 min prior to freezing 
grids for cryo-EM. As an alternative to size exclusion chromatography, the SIVrcm strand 
transfer intasome complexes were purified by ultracentrifugation through 2-ml 15-55 % 
(w/v) sucrose; the gradients were prepared manually by overlaying 400 µl 15, 25, 35, 45 and 
55% sucrose in 350 mM NaCl, 25 mM HEPES-NaOH, pH 7.0 and incubating at room 
temperature for 3-4 h to allow diffusion. The intasome assembly mixture overlaid on top of 
the gradient was spun in a SW55Ti rotor at 42,000 rpm at 4°C for 16.75 h, and 77-µl fractions 
taken from the top of the gradient were processed for negative stain EM (fig. S22).  
    To detect strand transfer activity of the HIV-1 or SIVrcm intasomes, 19.5 µl of each size 
exclusion chromatography fraction was supplemented with an equal volume of 10 mM DTT, 
8 µM ZnCl2 and 25 mM BTP pH 6.0 (resulting in final NaCl concentration of 175 mM). The 
reactions were initiated by addition of 300 ng pGEM target DNA and 10 mM MgSO4 in a 
final reaction volume of 40 µl. Samples were incubated at 37°C for 1 h and stopped by 
addition of 0.25% SDS and 12.5 mM EDTA. Reaction products, deproteinized by digestion 
with proteinase K and ethanol precipitation, were separated by agarose gel electrophoresis 
and visualized with ethidium bromide (fig. S3).  
 
Electron microscopy 
For negative stain analyses, 4-µl drops of freshly assembled and purified SIVrcm or HIV-1 
intasomes were spotted on carbon-coated 300-mesh copper grids (EM Resolutions, catalogue 
#C300Cu), which were glow-discharged for 30 sec at 45 mA using a K100X instrument 
(EMS). Excess sample was blotted and absorbed particles were stained with 2% uranyl 
acetate. Grids were imaged on a Tecnai G2 Spirit LaB6 transmission 120-keV electron 
microscope (FEI) with an Ultrascan-1000 camera (Gatan) at 30,000x nominal magnification, 
resulting in a magnified pixel size of 3.45 Å, with total electron exposure of 35 e/Å2 and 
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defocus range of 0.5-2.0 μm. A total of 1,376 micrographs were collected from negatively 
stained SIVrcm intasomes partially purified by velocity centrifugation through sucrose 
gradients (fig. S22) and 469 micrographs from HIV-1 intasomes isolated by size exclusion 
chromatography (fig. S3B).  
    Initial cryo-EM datasets were collected on SIVrcm intasomes spotted on carbon-coated 
grids under conditions previously optimized for the maedi-visna virus intasome (14). Briefly, 
ultrathin carbon-coated lacey grids (Ted Pella, catalogue #01824) were pre-treated by glow 
discharging for 1 min at 45 mA in the K100X instrument. Four µl intasome sample (A260 nm = 
0.2) freshly isolated by size exclusion chromatography was spotted on a grid at 22°C and 
95% humidity. After 1 min incubation, the grid was blotted (Agar Scientific blotting paper, 
catalogue #47000-100) on both sides for 0.5 sec, followed by immediate application of 4 µl 
wash buffer (200 mM NaCl, 25 mM HEPES-NaOH, pH7.0) and second blotting on both 
sides for 2-3 sec prior to freezing in liquid ethane using a Vitrobot Mark IV instrument (FEI). 
Blot force was set to -1 for all samples. The movies were recorded on a Tecnai G2 Polara 
(FEI) microscope operating at 300 kV and equipped with a K2 Summit direct electron 
detector (Gatan) with a total electron exposure of 50 e/Å2 over 40 frames (fig. S23A).  
    For the final high-resolution reconstructions, Apo SIVrcm intasome or its complexes with 
DTG or BIC, freshly isolated by size exclusion chromatography (A260 nm = 0.2 - 0.7), were 
spotted on C-flat holey carbon grids (EMS, catalogue #CF-1.2/1.3-4Au). The use of fresh C-
flat grids and omitting glow discharging was essential to observe intasomes in open holes. 
Following 1-min incubation at 22°C and 95% humidity, the grids were blotted (Agar 
Scientific blotting paper, catalogue #47000-100) on both sides for 1-2 sec and plunged into 
liquid ethane using Vitrobot Mark IV. Data were collected on Titan Krios microscope 
operating at 300 keV and equipped with a Gatan post-column energy filter, selecting a 20-
eV window, on a K2 Summit direct electron detector (Gatan). A total of 8,311 (Apo SIVrcm 
intasome), 6,961 (DTG-bound SIVrcm intasome), 11,846 (BIC-bound SIVrcm intasome), 
and 6,775 (BIC-bound Q148H/G140S SIVrcm intasome) movies were recorded using single 
electron counting mode with a defocus range of 1.6-3.5 µm. The total electron exposure was 
50.4 e/Å2 spread over 30 frames for datasets with a pixel size of 1.38 Å (Apo intasome, DTG-
intasome, and BIC-Q148H/G140S intasome) or 55.7 e/Å2 over 40 frames for the pixel size 
1.08 Å (BIC-intasome) (table S1, fig. S24A). The movies were aligned with dose weighting, 
as implemented in MotionCor2 (27), and the contrast transfer function (CTF) parameters 
were estimated from the frame sums using Gctf-v1.06 (28). After discarding images with ice 
contamination, the datasets contained the totals of 8,027 (Apo SIVrcm intasome), 6,838 
(DTG-bound SIVrcm intasome), 11,769 (BIC-bound SIVrcm intasome), and 6,618 (BIC-
bound Q148H/G140S SIVrcm intasome) movies.  
 
Single-particle image processing and structure refinement 
Negatively stained intasome particles were picked using semi-automatic mode of EMAN 
boxer (29) and subjected to reference-free 2D classifications in Relion-2.1 (30). For cryo-
EM image processing, SIVrcm intasome particles were initially picked along with linear 
polymer assemblies using EMAN boxer on a subset of micrographs of carbon-coated lacey 
grids. These were subjected to reference-free 2D classification in Relion-2.1. The resulting 
2D classes, low-pass filtered to 20 Å resolution, were used as references to pick particles on 
1,989 micrographs with relion_autopick. Following three rounds of reference-free 2D 
classifications in Relion-2.1, 71,983 particles were selected for a 3D classification. An ab 
initio reconstruction, created using cryoSPARC (31), was used as a reference for 3D 
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classification without symmetry and classified into three classes in Relion-2.1. Refinement 
of the best class containing 21,108 particles and with C2 symmetry applied to the CIC 
assembly produced the initial reconstruction at a sub-nm resolution (~8.5 Å) (fig. S23B). 
These results encouraged us to further optimize sample preparation. Strong density in the 
target DNA pose (fig. S23B) suggested that a considerable fraction of the intasomes captured 
DNA from the excess of vDNA present in the assembly reactions. To avoid competition 
between DNA and INSTIs for the intasome active sites, the A119D variant of SIVrcm IN 
was used for all further cryo-EM experiments. The mutation in orthologous retroviral INs 
specifically blocked target DNA capture without affecting IN active site function (16-18). 
    Datasets of SIVrcm intasomes collected on C-Flat holey carbon grids were exhaustively 
picked with Gautomatch (http://www.mrc-lmb.cam.ac.uk/kzhang/) and relion_autopick 
using two sets of low-pass filtered 2D classes as templates. Particle sets were in-silico 
purified by two consecutive rounds of reference-free 2D classification in cryoSPARC, and 
those belonging to well-defined classes (fig. S24B) were subjected to a crude 3D 
classification in Relion into four classes without applying symmetry (fig. S25). At this point, 
relion_autopick and Gautomatch subsets contributing to the best 3D class were combined, 
and overlapping particles were pruned using the dedicated script from the LocalRec package 
(32) with proximity cut-offs of at least 35 Å (25 or 40 pixels depending on the pixel size). 
This procedure resulted in 829,709 (Apo intasome), 739,798 (DTG-intasome), 675,894 
(BIC-intasome) and 866,839 (BIC-Q148H/G148S intasome) particles. 3D reconstructions 
from these particles were used to estimate positions and pick neighboring intasome repeat 
units along the stacks (fig. S25) by multiplying the translation vectors relating central 
(picked) repeat units to the neighboring (potentially unpicked) units by the Euler matrix 
specific to each refined particle. 
    The translational symmetry-expanded Apo intasome dataset, pruned for overlaps and 
containing 2,061,407 particles, was subjected to 3D classification into eighteen classes 
without imposing symmetry (fig. S25). Combination of the six highest-resolution 3D classes 
(boxed in the figure) yielded 644,674 particles. At this point, local defocus parameters 
determined with Gctf were added, and the particles were used in a 3D reconstruction 
imposing 2-fold symmetry. The particles were then sorted into two 3D classes without 
realignment in Relion and with a soft mask focusing on a single intasome stack unit 
(comprising IN octamer plus associated vDNA); 171,893 particles contributing to the high-
resolution class were then used for the final non-uniform 3D refinement as implemented in 
cryoSPARC, using default parameters (fig. S25). 
    Similar workflows were used to determine drug-bound SIVrcm intasome structures. The 
expanded DTG-intasome dataset containing 1,843,630 particles was first subjected to a crude 
3D classification in Relion into four classes, and the best class containing 825,295 non-
overlapping particles was further sorted into twelve 3D classes; 530,679 non-overlapping 
particles contributing to the best nine 3D classes were taken for per-particle motion correction 
(polishing) as implemented in Relion. Following 3D reconstruction, using locally determined 
CTF parameters, the dataset was further sorted into two 3D classes without re-alignment in 
Relion and with a soft mask focusing on one stack unit; the 178,295 particles contributing to 
the high-resolution class were used for the final non-uniform 3D refinement in cryoSPARC, 
using default parameters.  
    The expanded BIC-intasome dataset containing 1,415,850 particles was subjected to 3D 
classification in Relion into twelve 3D classes, and the best six classes collectively containing 
643,721 non-overlapping particles were taken for polishing. Following 3D reconstruction, 
using locally determined CTF parameters, the dataset was sorted into two 3D classes without 
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realignment in Relion imposing a soft mask focusing on one stack unit; 149,779 particles 
contributing to the high-resolution class were used for the final non-uniform 3D refinement 
in cryoSPARC, using default parameters. Map sharpening and filtering was done in 
cryoSPARC, and Blocres (33) was used for local resolution estimation (fig. S8). 
Q148H/G140S SIVrcm intasomes assembled less efficiently forming shorter stacks, and 
translation symmetry expansion did not increase the number of particles. Following a 3D 
reconstruction using 866,839 particles of the BIC-Q148H/G140S intasome complex derived 
from the initial 3D classification, the dataset was sorted into two 3D classes without 
realignment imposing a soft mask focusing on one stack unit, and 213,635 particles 
contributing to the high-resolution class were used in the final non-uniform refinement in 
cryoSPARC, using default parameters and locally estimated determined CTF parameters.  
    Gold standard FSC = 0.143 criterion (34, 35) was used to estimate resolutions of the 3D 
reconstructions (fig. S7, table S1). Heat maps of angular distributions of refined particles for 
the reconstructions are shown in fig. S26. The final cryo-EM maps lacked anisotropic 
features, and 3D FSC sphericity values (36) ranged between 0.960 and 0.975 (table S1).  
    The atomic models, initially assembled by rigid docking of partial and homologous 
structures (PDB IDs 1EX4, 1K6Y, 2B4J, and 5U1C) (9, 37-39), were manually fitted into 
sharpened cryo-EM maps and extended in Coot (40). Water molecules discernible in half-
maps were included in the refinement (fig. S27); strong cryo-EM density peak underlying 
side chain of Tyr143 was tentatively interpreted as a Cl- anion. The final refinement was done 
using the real-space engine from Phenix software package (41) using default restraints and 
automatic weight settings; to preserve 2-fold symmetry of the assembly, non-crystallographic 
symmetry constraints for the two halves of the intasome were enforced during refinement. 
Quality of the final models were assessed using MolProbity (42) and EMRinger (43) (table 
S1). 
 
Single-cycle HIV-1 and SIVrcm infectivity assays 
The SIVrcm sequence (NCBI entry HM803689) (10) from the upstream R region to 
downstream CAAGT in U5 was synthesized by BioBasic and inserted into pcDNA3.1+ 
vector DNA at BamHI and XhoI restriction enzyme sites; the resulting pSIVrcm-Luc 
construct harboured a 1,216 bp deletion in the env gene that encoded for the surface subunit 
of the envelope glycoprotein, as well as the substitution of firefly luciferase for the Nef 
coding region (fig. S11A). To aid mutagenesis, the IN-coding region of pSIVrcm-Luc was 
flanked with SanDI and Bsu36I restriction sites by introducing silent point mutations into pol 
(region encoding reverse transcriptase (RT)) and vif, respectively. This made it possible to 
shuttle SanDI-Bsu36I DNA fragments encoding IN variants into the virus construct. To allow 
digestion with SanDI, the viral DNA construct was isolated from methylation-negative dam-
/dcm- E. coli cells (New England Biolabs). For all other purposes, the DNA was propagated 
in Stbl3 cells (ThermoFisher Scientific) at 30°C. Single-round WT and Q148H/G140S HIV-
1 luciferase reporter constructs and pCG-VSV-G were previously described (44, 45). 
Q148H/G140S DNA was mutagenized by QuickChange II site directed mutagenesis 
(Agilent). All viral expression constructs used for infectivity assays were verified by 
sequencing of the entire proviral genomes. 
    HEK293T cells cultured in Dulbecco’s modified Eagle medium supplemented with 10% 
fetal bovine serum, 100 IU/mL penicillin, and 100 µg/mL streptomycin (DMEM) at 37 oC 
were transfected with proviral DNA and pCG-VSV-G constructs at the ratio of 9:1 (15 µg 
total DNA per 10-cm dish) using PolyJet (SignaGen). Culture supernatants harvested 48 h 
after transfection pre-cleared for cell debris were filtered through 0.45 µm filters and 
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concentrated by ultracentrifugation at 4 °C for 2 h at 26,000 rpm in a SW32-Ti rotor. Virus 
pellets resuspended in DMEM were frozen in aliquots and stored at -80°C. Virus yield was 
quantified by a Taqman-based product-enhanced RT assay (Taq-PERT) as follows. Viruses 
diluted in water were treated with 2x lysis buffer (0.25% Triton X-100, 50 mM KCl, 100 mM 
Tris-HCl pH 7.4, 40% glycerol) in the presence of RNase inhibitor. Bacteriophage MS2 
genomic RNA was used as the template for the reverse transcription reaction with primers 
AE7575 (5’-TCCTGCTCAACTTCCTGTCGA) and AE7576 (5’-CACAGGTCAAACCTC 
CTAGGAATG) and Taq-man probe 6[FAM]CGAGACGCTACCATGGCTATCGCT 
GTAG[TAMsp] (46). RT activity was expressed as mU/mL as determined by standard curves 
generated using recombinant HIV-1 RT protein (Millipore). 
    In preliminary experiments (fig. S11A), HEK293T cells (100,000 per well of a 24 well-
plate) were infected in duplicate with 0.5 µU RT per cell. After 6-8 h, media was replaced 
with fresh DMEM, and cell cultures were harvested at 48 h from the start of the experiment. 
Cells were lysed in passive lysis buffer (Promega) by freezing overnight at -80 oC and 
thawing at 37 oC for 30 min. Cell lysates were centrifuged at 17,500 g for 8 min, and 
supernatants were analyzed in triplicate for luciferase activity. Relative light units (RLU), 
determined by luminometer (Berthold Technologies), were normalized to total protein 
concentration as measured by bicinchoninic acid protein assay kit (Thermo Fisher Scientific). 
    For drug sensitivity assays, HEK293T cells (10,000 per well of a 96-well plate) were 
infected in triplicate with WT or IN mutant SIVrcm or HIV-1 virus at 0.5 µU RT activity/cell 
in 200 μL DMEM medium with 8-10 concentrations of INSTIs in 4-fold dilution steps that 
ranged from no drug to 2 μM or 20 μM. At 6-8 h post-infection, the virus-containing media 
was exchanged for fresh media. At 48 h post-infection, cells were washed twice with 
phosphate-buffered saline and lysed in 5X passive lysis buffer (Promega) by freezing at -80 
oC for 30 min and thawing at 37 oC for 20 min. Insoluble material was pelleted by 
centrifugation, and luciferase activity was assessed for supernatants. EC50 values were 
calculated from two independent experiments by fitting to a dose-response-inhibition (four 
parameters) model using GraphPad Prism 8 software. Fold changes in EC50 against mutant 
viruses relative to WT control virus were calculated using mean EC50 values from two 
independent experiments. P values <0.05 as assessed by Student’s paired t-test with two-
tailed distribution were considered significant. 
 
Tritium SPA assay 
INSTI dissociation measurements were done according to published protocols (21, 47) with 
minor modifications. Biotinylated HIV-1 U5 vDNA (0.6 nmol) prepared by annealing 
synthetic oligonucleotides 5'-Biotin-TEG-CCAGTCAGTGTGGAAAATCTCTAGCA and 
5'-ACTGCTAGAGATTTTCCACACTGACTGG was immobilized on 10 mg streptavidin-
coated polyvinyl toluene beads (Perkin Elmer). The beads were washed and resuspended in 
50 mM NaCl, 10 mM MgSO4, 25 mM HEPES-NaOH, pH 7.0 in a total volume of 200 µl, 
and 150 µl suspension was diluted with 2.1 ml SPA buffer (100 mM NaCl, 25 mM MgSO4, 
13 mM DTT, 6% polyethylene glycol 400, 0.06% Nonidet P40, 30 mM HEPES-NaOH, pH 
7.0). Bead suspensions were supplemented with 0.5 µM WT or Q148H/G140S HIV-1 IN. 
Upon incubation at 37oC for 80 min to form the IN-vDNA complexes, the beads were washed 
and resuspended in equivalent volume of SPA buffer prior to addition 0.5 µM 3H-labeled 
DTG or analog 1. The inhibitors were allowed to bind overnight at room temperature. The 
following morning beads were transferred into white 96-well OptiPlate plates (Perkin Elmer) 
at 100 µl suspension per well. Dissociation was induced by addition of 100 µM unlabeled 
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compound, and the scintillation signal was measured using a TopCount instrument (Perkin 
Elmer). For consistency, the plates were kept at room temperature for the entire length of the 
experiment and gently mixed to suspend the SPA beads prior to each measurement. Signals 
from duplicate wells were averaged, and signals measured from protein-free controls were 
subtracted. 
 
Molecular Dynamics (MD) 
MD simulations were performed for four systems: the wild type and Q148H/G140S SIVrcm 
intasome bound to two types of ligands: BIC and analog 1. The initial models were assembled 
based on the experimental structures determined in this work, using N-terminal acetyl and 
C-terminal amide capping groups for missing residues. The ligands were parametrized using 
the general Amber force field (GAFF) (48). The atomic partial charges were obtained from 
electrostatic potential calculations (49) at the level of density functional theory (DFT) 
ωB97X-D/def2TZVPP as implemented in Gaussian 09 Revision E (50-52). The system was 
solvated by 100,000 - 120,000 TIP3P water molecules depending on the ligand and mutations 
and neutralized with Na+ and Cl- ions. From the original starting cryo-EM structure, water 
molecules directly involved in the metal coordination were retained. The system was 
minimized using a standard protocol via steepest descent algorithm for a total number of 
150,000 steps, followed by 10 ns equilibration with restrained heavy atoms (heavy atom of 
the backbone of the protein and the nucleic with an isotropic force of 1000 kJ mol-1nm-1) in 
constant number pressure and temperature (NPT) and constant number volume and 
temperature (NVT; up to 1 ns) at 300 K via standard MD procedure using NAMD 2.12 (53). 
A series of unbiased MD simulations were performed for the four systems (wild type and 
G140S/Q148H IN bound with BIC or analog 1) to obtain multiple independent trajectories. 
A total of 10 replicas were run for all systems, and each simulation was 100 ns long.  
 
Quantum Mechanics/Molecular Mechanics (QM/MM) 
The experimentally resolved structures were subject to QM/MM minimizations to obtain 
geometry-optimized structures of the active site at the ab initio DFT level and assess the 
quantitative response of the ligand bound structures to the mutations. The MM region was 
described by CHARMM36 force field (54) while the hybrid functional B3LYP (55) with the 
GTO basis set of 6-31G* (56-58) was utilized for the active site, as implemented in 
CHARMM (59) and Q-Chem 4.3 (60), respectively. QM/MM calculations were performed 
in a non-periodic fashion, with atoms further than 25 Å from the ligand removed while those 
between 20 and 25 Å were fixed. Population analysis was carried out for the QM region 
embedding the electrostatics of the MM atoms (61), using natural bond orbital (NBO) 3.1 
scheme (62, 63), as implemented in Gaussian 09 Revision E. 
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Fig. S1: Amino acid sequence alignment of SIVrcm and HIV-1 INs. Boxes highlight IN 
domains (NTD; catalytic core domain, CCD; and CTD); secondary structural elements are 
indicated atop the alignment. Filled triangles and stars respectively indicate positions 
corresponding to mutations associated with INSTI resistance and residues comprising the 
active site (metal-chelating) DDE triad. Red highlights positions of amino acid identity; 
yellow, chemically-related amino acids. Shown is laboratory-derived HIV-1 subtype B strain 
NL4-3 (NCBI entry U26942.1). Percent SIVrcm IN amino acid identity is similar to 
circulating HIV-1 subtypes, such as clade C transmitter-founder strain Z331M (accession 
code KR820323; 75.0% identical) and clade A1 strain Q23-17 (AF004885; 74.7% identical). 
Polymorphic position 74, substitutions at which are associated with increased INSTI 
resistance, is frequently occupied by Ile in HIV-1 isolates from INSTI-naïve patients 
(https://hivdb.stanford.edu/dr-summary/resistance-notes/INSTI/). The figure was prepared 
using ESPript software (64). 
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Fig. S2: Strand transfer activity of SIVrcm IN in vitro. Schematic of the reaction products 
(top). Full-site product (left) is generated by insertion of a pair of viral DNA (vDNA) ends, 
mimicked by oligonucleotides corresponding to pre-processed U5 vDNA (red lines) into 
opposing strands of target DNA (pGEM plasmid DNA, black lines). Half-site product (right) 
is generated by insertion of a single vDNA end. Analysis of strand transfer products in the 
absence or presence of increasing concentrations of LEDGF/p75 by agarose gel 
electrophoresis, detected by staining with ethidium bromide. The left- and the right-most 
lanes contained mock samples prepared in the absence of proteins and vDNA, respectively; 
the latter control verified the absence of nuclease contamination in recombinant IN and 
LEDGF/p75 protein preparations. Input concentrations of SIVrcm IN and LEDGF/p75 are 
shown above the gel. Migration positions of DNA size markers and specific reaction products 
are indicated (o.c., open circular; s.c., supercoiled). Products of multiple strand transfer 
events appear as a smear and become prominent when circular target DNA is expended.  
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Fig. S3: Assembly and activity of SIVrcm (A) and HIV-1 (B) intasomes. Intasome 
assembly mixtures were separated by size exclusion chromatography (left) and specific 
fractions were tested for strand transfer activity using supercoiled pGEM plasmid target DNA 
(right). Elution positions of the intasomes, free protein, and vDNA oligonucleotides are 
indicated above the chromatograms. In addition, the peak fraction of the SIVrcm intasome 
with elution volume 5.64 ml was tested in the absence or presence of DTG (from left to right: 
0, 10, 50, 100, 500, 1000 nM). Chromatograms are representative of n>10 and n=3 SIVrcm 
and HIV-1 intasome preparations, respectively; agarose gel images represent minimally two 
independent experimental replicates. 
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Fig. S4: Distribution of negatively stained SIVrcm intasomes between 2D classes. 
SIVrcm intasomes were fractionated by sedimentation through sucrose gradient (fig. S22). 
Particles eluting at 1.5 ml of the gradient were imaged by negative-stain EM and subjected 
to reference-free 2D classification. Percentages of particles belonging to single and stacked 
intasome classes are given in the first and second columns; the apparent number of IN 
subunits in the classes is shown in the third column. The corresponding 2D classes are shown 
to the right.  
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Fig. S5: Negative-stain EM of HIV-1 intasomes. A raw micrograph of HIV-1 intasomes 
isolated by size-exclusion chromatography and stained with uranyl acetate (top) and 
examples of 2D class averages (bottom). Particle distributions between 2D classes are given 
in fig. S6. One of the class averages that contains 12 apparent IN protomers (lower left, blue 
circle) resembles the dodecamer assembly reported previously for a hyperactive HIV-1 IN-
Sso7d fusion protein (9). For comparison, 2D classes of MVV intasomes (14) are shown at 
the bottom; apparent numbers of IN subunits are indicated for non-stacked classes. Low-pass 
filtered envelope of the hexadecameric MVV intasome structure (red circle) is shown for 
comparison with central and flanking IN tetramers in blue/green and yellow, respectively. 
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Fig. S6: Distribution of negatively stained HIV-1 intasome between 2D classes. HIV-1 
intasomes isolated by size-exclusion chromatography (fig. S3B) were imaged by negative-
stain EM and subjected to reference-free 2D classification. Percentages of intasome particles 
belonging to single and stacked intasome classes are given in the first and second columns; 
the apparent number of IN subunits in the classes is shown in the third column. The 
corresponding 2D classes are shown to the right.  
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Fig. S7: Fourier shell correlation of maps from independent particle half-sets for Apo, 
DTG-bound, BIC-bound WT SIVrcm intasome, and BIC-bound Q148H/G140S 
SIVrcm intasome. Correlations were calculated without or with soft-edge masks around a 
single stack unit, or for the CIC (grey, blue, and red lines, respectively); corresponding 
resolutions at the correlation thresholds of 0.143 and 0.5 are indicated. Green lines represent 
FSCs between refined models and the corresponding cryo-EM maps.  
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Fig. S8: Local resolution maps of Apo, DTG-, and BIC-bound WT SIVrcm intasomes 
and BIC-bound Q148H/G140S SIVrcm intasome. The left and middle images show the 
full map at a low and a high-density threshold, respectively. Views focused on the active sites 
with color scale are shown to the right. Locations of selected protein residues, 3' vDNA 
nucleotide (dA), and drug molecules are indicated.  
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Fig. S9: Examples of cryo-EM density of the Apo SIVrcm intasome. Stereo views (wall-
eye format) of IN chain A active site region and Zn-binding cluster of the NTD are shown 
on top and bottom, respectively. Cryo-EM density is shown as blue chicken wire. Protein and 
DNA residues are shown as sticks with carbon atoms in green and grey, respectively; the 
grey sphere represents a Zn2+ ion coordinated by the invariant His and Cys residues of the 
NTD. Selected amino acid residues and the nucleotides comprising the invariant dCdA 3' 
dinucleotide of the vDNA plus-strand are indicated on the stereo-views; 3' deoxyadenosine, 
which is displaced by INSTIs in drug-bound structures, is highlighted with an asterisk. 
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Fig. S10: Comparison of hexadecameric MVV intasome, SIVrcm stack (middle), and 
dodecameric HIV-1 intasome (bottom) reconstructions. MVV intasome (EMDB-4138, 
PDB ID 5m0q; top) (14), SIVrcm stack (this work; middle), and HIV-1 intasome (EMDB-
8483; bottom) (9) are shown as cartoons with helices as tubes. The IN tetramers providing 
the active sites in MVV and HIV intasomes are green, and flanking structures, which donate 
the synaptic CTDs, are orange and purple; vDNA is grey. The structures are shown in the 
same orientation and scale. A pair of IN dimers belonging to the flanking tetramers (indicated 
with dotted circles on the MVV intasome structure) is missing in the reported HIV-1 
intasome. Corresponding IN dimers of the flanking repeat units in the case of the SIVrcm 
stack contribute to the CIC structure. Expansion of the SIVrcm stack is aided by the mobility 
(red arrow in boxed views to the right) of the two CTDs belonging to an adjacent central 
tetramer (chains C and K; orange), which allows them to assume synaptic positions within 
the neighboring stack units. Cyan and yellow are outermost NTDs and CTDs from adjacently 
stacked leftward and rightward IN-vDNA units, respectively. Note the striking similarity of 
the common elements among the three structures.  
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Fig. S11: Reconstruction and characterization of SIVrcm recombinant virus. (A) To-
scale genomic map of pSIVrcm-Luc compared with parental SIVrcm provirus. Heterologous 
elements (CMV promoter in place of upstream U3; firefly luciferase in place of Nef) are 
noted. Lower, Infectivity of RT mU-matched SIVrcm-Luc (with silent mutations in pol and 
vif) and HIV1-Luc at three different levels of viral inocula. Results are averages and standard 
deviations of minimally n = 2 independent experiments, with each experiment conducted in 
duplicate. (B) Fold changes in EC50 values of noted IN mutants versus respective WT HIV-1 
and SIVrcm viruses. Results are averages and standard deviations of n = 2 experiments with 
each experiment conducted in triplicate. BIC and DTG displayed similar EC50 values (p > 
0.5) against each tested mutant virus. The data for G140S/Q148H/T97A/L74M HIV-1 is 
from ref. (7). 
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Fig. S12: Examples of cryo-EM density of DTG-bound SIVrcm intasome. Stereo views 
of IN chain A active site region and Zn-binding cluster of the NTD are shown on top and 
bottom, respectively. The cryo-EM density and the refined model are depicted and labeled 
as in fig. S9. In addition, the INSTI (DTG) molecule is shown as sticks with carbon atoms in 
magenta; red and grey spheres are water molecules and metal ions, respectively. 
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Fig. S13: Examples of cryo-EM density of BIC-bound SIVrcm intasome. Stereo views 
show IN chain A active site region (top and middle) and Zn-binding cluster of the NTD 
(bottom). The cryo-EM density and the refined model are depicted as in figs S9 and S12. The 
key W5 water molecule with corresponding distances is shown in the middle stereo view. 
See fig. S21 for a view focusing on Ile74 and Thr97.   
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Fig. S14: Rearrangement of the intasome active site from INSTI binding. Active site 
regions of the APO and BIC-bound WT SIVrcm intasomes are shown as sticks with carbon 
atoms colored as in the inset (bottom left). Grey spheres are Mg2+ ions. Selected IN amino 
acid residues and the invariant 3' vDNA dCdA dinucleotide are indicated. Note the 
displacement of 3' vDNA deoxyadenosine (asterisk) in the INSTI-bound structure as 
indicated by the curved arrow.  
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Fig. S15: Comparison of SIVrcm intasome-DTG with PFV intasome-DTG (top) and 
SIVrcm intasome-BIC (bottom) complexes. PFV intasome-DTG is an X-ray structure 
(PDB entry 3S3M) refined at 2.5 Å resolution. The structures, which were superposed by Ca 
atoms of the invariant active site residues, are shown as sticks with carbon atoms and Mg2+ 
ions (spheres) colored as indicated on the inset to the right. Selected SIVrcm IN amino acid 
residues and the invariant 3' vDNA dCdA dinucleotide are labeled; the deoxyadenosine 
displaced by the bound inhibitor is indicated with an asterisk. One crucial difference between 
the PFV and SIVrcm structures is the replacement of Gln148 with a Ser in the spumavirus, 
which cannot coordinate a water molecule with carboxylate Asp and Glu sidechains as does 
Gln148 in the SIVrcm intasome. The r.m.s. deviation between eleven Ca atoms of the 
residues in the immediate vicinity of the bound drugs is 0.58 Å. Thus, the overall 
conformations of the PFV and SIVrcm active sites are sufficiently discordant to affect 
geometric fit of the bound drug molecule. Furthermore, the packing of the displaced vDNA 
3' adenosine against the metal chelating core of DTG differ between the SIVrcm and PFV 
structures (top panel). Finally, in accordance with the scarce overall amino acid sequence 
identity, the SIVrcm and PFV structures become highly divergent immediately outside of the 
active sites, where many secondary amino acid substitutions that enhance the levels of 
INSTI-resistance occur. By contrast, the differences between DTG and BIC-bound SIVrcm 
intasomes are subtle (bottom panel).  
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Fig. S16: Behavior of water molecules shared by Gln148 or His148 and active site 
carboxylates. (A) The structure of WT SIVrcm intasome bound to BIC was stripped of water 
molecules not directly coordinated to metal ions, embedded in bulk solvent, and subjected to 
100 ns of molecular dynamics. The bulk solvent-derived water molecule closest to Gln148 
Ne2 and the carboxylates of Glu152 and Asp116 was identified in each frame of the 
simulation. The dot plots report the corresponding distances every 0.1 ns of the molecular 
dynamics. The position corresponding to that occupied by W5 in the structure becomes 
occupied by a stably bound water molecule during the initial 5 ns of the simulation. 
Alterations of dot colors correspond to exchanges of the water molecule with bulk solvent. 
(B) A similar analysis with the Q148H/G140S SIVrcm BIC structure. Here, a water molecule 
closest to His148 Ne2 and the carboxylates of Glu152 and Asp116 was identified in each 
frame of the simulation. Note frequent exchanges with bulk solvent; ~4 Å is considered to 
be the upper limit for hydrogen bonding. 
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Fig. S17: Examples of cryo-EM density of BIC-bound Q148H/G140S SIVrcm intasome 
and details of the interactions in the active site. (A) The stereo views show IN chain A 
active site region (top) and details of the key involving His148 and Ser140 residues with 
corresponding interatomic distances in Ångstroms (bottom). The cryo-EM density and the 
refined model are depicted as in figs S9 and S12. See fig. S20 for a view focusing on Thr138 
and His114. (B) Packing of His148 side chain in the active site of the Q148H/G140S 
intasome. Select residues of the Q148H/G140S (green with magenta BIC) and WT (grey 
residues and drug) structures are shown as overlaid sticks (top) or Van der Waals spheres 
(bottom; only Q148H/G140S structure shown); d+ indicates increased electropositivity of 
the His148 Ne2 proton.  
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Fig. S18: Dynamics of BIC and analog 1 in the intasome active site. WT and 
Q148H/G140S SIVrcm intasomes bound to BIC or analog 1 were subjected to MD 
simulation. The resulting frames (12,500 structures derived from a total of 250 ns simulation 
per condition) were aligned by Ca atoms of intasome active site residues. (A) Subset of 10 
WT intasome-BIC complex frames separated by 10 ns of simulation. Protein and DNA 
shown as cartoons and BIC as sticks. DNA is colored gray and protein is colored according 
to r.m.s. deviation from the initial position (blue, small displacement; red large 
displacement); the IN CTD and visible secondary structure elements of the CCD are 
indicated. (B) BIC and analog 1 with the common carbon atoms closest to the b4-a2 
connector when bound to the intasome active site indicated with red circles; arrowheads show 
direction of displacement chosen for the analysis. (C) Probability density for a given 
displacement of the chosen BIC (blue) or analog 1 (orange) carbon atom from the initial 
plane defined by bolded atoms in panel B in complex with WT (top) or Q148H/G140S 
(bottom) intasome. Full width at half maximum (FWHM) is listed for each distribution. Note 
a wider distribution of the atomic displacements in the case of analog 1. 
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Fig. S19: Active site polarizability changes due to Q148H/G140S substitutions for BIC 
(top) and analog 1 (bottom).  Natural bond orbital analysis results are shown for the active 
site Mg2+-ligand cluster. Protein residues, bound ligands, and metal ions from QM/MM 
minimized structures are represented as sticks and semi-transparent space-fill spheres. Colors 
indicate changes in charge distributions between the Q148H/G140S mutant and the wild type. 
Note the increased change in polarization of the metal chelating atoms of analog 1 due to the 
amino acid substitutions. 
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Fig. S20: The extended hydrogen bond network coupling Thr138 to His148 in the 
Q148H/G140S SIVrcm intasome. Cryo-EM map of Q148H/G140S SIVrcm intasome-BIC 
centered on the region shown in Fig. 2E. The cryo-EM density and the refined model are 
depicted as in figs S9 and S12.  
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Fig. S21: Long-range interactions of Ile74 and Thr97 with the metal chelating cluster 
of the IN active site.  (A) Cryo-EM map of WT SIVrcm intasome-BIC centered in the region 
shown in Fig. 2F, revealing definition of the side chain rotamers. The cryo-EM density and 
the refined model are depicted as in figs S9 and S12. (B) Effect of I74M/T97A substitutions 
on the conformation of Phe121. Models of Q148H/G140S SIVrcm-BIC intasome with and 
without the I74M/T97A substitutions were subjected to 100 ns of molecular dynamics. The 
graphs illustrate a shift in Phe121 Cb-Cg dihedral angle distributions in response to the 
I74M/T97A changes. Because Phe121 side chain intimately interacts with the Asp116 
carboxylate (panel A and Fig. 2F), its conformation and dynamics are expected to directly 
affect the metal coordination cluster. 
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Fig. S22: Fractionation of SIVrcm intasomes by velocity sedimentation. SIVrcm strand 
transfer intasome assembly reactions were separated by ultracentrifugation through a 15-55% 
sucrose gradient; mean A260 (red) and A280 (blue) values for each fraction are plotted (error 
bars are from three independent experiments), and positions of free DNA oligonucleotide, 
protein, and intasomes are indicated. Selected fractions were analyzed by negative-stain EM 
(bottom). 
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Fig. S23: Preliminary cryo-EM analysis of SIVrcm intasomes on ultrathin carbon-
coated lacey grids. A. Example of a raw micrograph. B. Results of 2D and 3D 
classifications, and 3D reconstruction; tDNA, target DNA. 
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Fig. S24: Example of a raw micrograph (A) and 2D class averages (B) of SIVrcm 
intasomes in vitreous ice on holey carbon grids.  
 
 
  
B 
A 
 
 
 
 
33 
 
 
 
 
(continued on the next page) 
 
  
 
 
 
 
34 
 
 
 
 
Fig. S25:  Schematic of image processing and reconstruction of the Apo SIVrcm 
intasome. Inset on the bottom right shows orthogonal real space slices of the refined map 
(top) and auto-mask applied during non-uniform refinement in cryoSPARC (bottom). Similar 
flow charts applied to data acquisition and reconstitution of DTG-bound and BIC bound wild-
type SIVrcm intasomes, as well as BIC-bound Q148H/G140S intasome; see Materials and 
Methods for details.  
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Fig. S26: Viewing direction distributions for the refined structures of Apo, DTG-bound, 
and BIC-bound WT SIVrcm intasomes and BIC-bound Q148H/G140S SIVrcm 
intasome. Heat maps represent particle number for each combination of refined azimuth and 
elevation, as indicated on the color scales to the right.   
  
  
  
  
APO 
DTG 
BIC 
BIC,  
Q148H/G140S 
 
 
 
 
 
36 
 
 
 
 
 
Fig. S27:  Half-maps for the active site region of the WT SIVrcm intasome in complex 
with BIC. The maps obtained by refinement of two independent particle half-sets (generated 
during the final non-uniform refinement in cryoSPARC and auto-sharpened in Phenix) are 
displayed as blue and red chicken wire. Small red spheres are water molecules. Protein, DNA, 
and BIC are shown as sticks, with carbon atoms in green, grey and magenta, respectively. 
Note the presence of density for the refined water molecules, including W5, in both half-
maps. 
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Table S1: Cryo-EM data collection and refinement.  
 Apo DTG BIC BIC Q148H/G140S 
Database accession codes     
 EMDB  EMD-10041 EMD-10043 EMD-10042 EMD-10044 
 RCSB  6RWL 6RWN 6RWM 6RWO 
Data collection     
 Microscope Titan Krios Titan Krios Titan Krios Titan Krios 
 Operating voltage (kV) 300 300 300 300 
 Detector Gatan K2 Gatan K2 Gatan K2 Gatan K2 
 Magnification nominal/calibrated 105,000/36,232 105,000/36,232 130,000/46,296 105,000/36,232 
 Pixel size (Å) 1.38 1.38 1.08 1.38 
 Defocus range (µm) 1.6-3.5 1.6-3.5 1.6-3.5 1.6-3.5 
 Number of frames per movie 30 30 40 30 
 Electron exposure rate (e/Å2/s) 4.2 4.2 5.6 4.2 
 Total electron exposure (e/Å2) 50.4 50.4 55.7 50.4 
 Energy filter slit width (eV) 20 20 20 20 
 Automation software EPU EPU EPU EPU 
 Total movies acquired/used 8,311/8,027 6,961/6,838 11,846/11,769 6,775/6,618 
 Movie alignment software  MotionCor2 MotionCor2 MotionCor2 MotionCor2 
Classification and 3D reconstruction      
 Software for 2D classification Cryosparc-1 Cryosparc-1 Cryosparc-1 Cryosparc-2 
 Software for 3D classification Relion-2.1 Relion-2.1 Relion-2.1 Relion-3.0 
 Software for reconstruction Cryosparc-2 Cryosparc-2 Cryosparc-2 Cryosparc-2 
 Number of extracted particles 6,235,062 5,370,417 6,426,769 5,642,300 
 Number of refined particles 171,893 178,294 149,778 217,635 
 Symmetry imposed  C2 C2 C2 C2 
 Map resolution (Å) a     
  Unmasked volume 4.6 (7.6) 4.3 (7.2) 3.9 (6.8) 4.2 (7.1) 
  Repeat unit  3.4 (3.9) 3.1 (3.4) 2.8 (3.1) 2.9 (3.3) 
  CIC  3.2 (3.6) 3.0 (3.3) 2.6 (3.0) 3.0 (3.2) 
  Active site local resolution 2.8 - 3.0 2.8 - 2.9 2.4 - 2.7 2.8 - 2.9 
 3D FSC sphericity 0.960 0.969 0.975 0.971 
Model refinement     
 Map sharpening B-factor (Å2) -170 -110 -95 -160 
 Software for real-space refinement Phenix Phenix Phenix Phenix 
 Model composition     
  Non-hydrogen atoms 18,272 18,346 18,450 18,366 
  Protein and DNA residues 2,165 2,165 2,165 2,159 
  Metal ions (Zn, Mg) 8 10 10 10 
  Water molecules 0 8 108 6 
  Ligands (INSTI) 0 2 2 2 
 Mean B factors (Å2)     
  Protein and DNA residues 65.5 25.1 34.6 54.1 
  Water - 12.0 18.3 23.6 
  Ligands (INSTI) - 10.3 14.1 26.0 
 Real-space correlation coefficient 0.8027 0.7974 0.7844 0.7961 
 R.m.s. deviations      
  Bonds (Å) 0.003 0.004 0.006 0.006 
  Angles (o) 0.504 0.560 0.675 0.640 
 Validation b     
  MolProbity clash score 2.63 2.62 2.40 2.29 
  Rotamer outliers (%) 2.86 3.66 3.20 4.10 
  Cb deviations (%) 0 0 0 0 
  CaBLAM outliers (%) 1.31 1.21 1.31 1.51 
  EMRinger score 2.24 3.05 3.78 3.08 
 Ramachandran plot quality (%)     
  Favored 96.95 96.85 96.11 96.65 
  Disallowed 0 0 0 0 
a Based on the FSC of 0.143 between half-sets (values for FSC of 0.5 are given in parentheses).  
b Assessed using MolProbity (42) and EMRinger (43). 
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Movie S1  
Atomic model of BIC-bound SIVrcm intasome fitted into the experimental cryo-EM density. 
Labelling indicates IN and vDNA residues, as well as bound Mg2+ ions and waters (turquoise 
and red spheres, respectively). Additional solute density was tentatively modelled as a 
chloride ion (chartreuse sphere). 
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